Association of TRPS1 rs2737229 and TRIB1 rs2954029 Genetic Polymorphisms with Subclinical Atherosclerosis, LDL Cholesterol, and Glucose Levels
Biology · 05.04.2026 · 15 (7) · 580
DOI: 10.3390/biology15070580 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biology, online erschienen am 05.04.2026. Verfasst von Gilberto Vargas-Alarcón und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Direction, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City 14080, Mexico. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Recent reports have shown that polymorphisms in the TRPS1 and TRIB1 genes are associated with plasma lipid levels and the risk of cardiovascular disease. This study evaluates the associations of TRPS1 and TRIB1 polymorphisms with subclinical atherosclerosis (SA) and plasma lipid levels in Mexican individuals. This study included 1406 Mexican mestizo individuals (417 individuals with SA and 989 healthy controls). Genotyping of TRPS1 and TRIB1 polymorphisms was performed using TaqMan assays in a real-time PCR system. To analyze whether these polymorphisms are associated with SA and plasma lipid levels, we used logistic regression (OR [95% CI]), adjusted for confounding factors. The AA genotype of the TRPS1 rs2737229 A/C polymorphism showed a significant association with the risk of developing SA under multiple genetic models [codominant: OR = 1.61 (95% CI: 1.10–2.36), p = 0.048; recessive: OR = 1.42 (1.02–1.99), p = 0.039; additive: OR = 1.26 (1.05–1.53), p = 0.015]. Similarly, the TT genotype of the TRIB1 rs2954029 T/A polymorphism was also significantly associated with the risk of developing SA [codominant: OR = 1.63 (1.10–2.43), p = 0.033; recessive: OR = 1.64 (1.13–2.37), p = 0.009]. In a sub-analysis of SA individuals, individuals with homozygous AA for the TRPS1 rs2737229 polymorphism had higher LDL cholesterol levels [135 mg/dL (110–148)] than those with homozygous CC [118 mg/dL (99–139)] (p < 0.003). The analysis of the TRIB1 rs2954029 polymorphism showed that carriers of the TT genotype had increased glucose levels [97 mg/dL (87–118)] compared to carriers of the AA genotype [91 mg/dL (84–99)] (p < 0.002). In summary, our findings showed that, in Mexican Mestizos, the AA genotype of the TRPS1 rs2737229 A/C SNP and the TT genotype of the TRIB1 rs2954029 A/T polymorphism are associated with a higher risk of developing SA and elevated levels of glucose and LDL cholesterol.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Direction, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City 14080, Mexico.
- Department of Endocrinology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City 14080, Mexico.
- Department of Molecular Biology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City 14080, Mexico.
ORCID-Profile: Gilberto Vargas-Alarcón, Rosalinda Posadas-Sánchez, Oscar Pérez-Méndez, Marva Arellano-González, José Manuel Fragoso
Zitieren
APA
Vargas-Alarcón, G., Posadas-Sánchez, R., Pérez-Méndez, O., Arellano-González, M., & Fragoso, J. M. (2026). Association of TRPS1 rs2737229 and TRIB1 rs2954029 Genetic Polymorphisms with Subclinical Atherosclerosis, LDL Cholesterol, and Glucose Levels. Biology, 15(7), 580. https://doi.org/10.3390/biology15070580
Vancouver
Vargas-Alarcón G, Posadas-Sánchez R, Pérez-Méndez O, Arellano-González M, Fragoso JM. Association of TRPS1 rs2737229 and TRIB1 rs2954029 Genetic Polymorphisms with Subclinical Atherosclerosis, LDL Cholesterol, and Glucose Levels. Biology. 2026;15(7):580. doi:10.3390/biology15070580
BibTeX
@article{VargasAlarcn2026,
author = {Vargas-Alarcón, Gilberto and Posadas-Sánchez, Rosalinda and Pérez-Méndez, Oscar and Arellano-González, Marva and Fragoso, José Manuel},
title = {Association of TRPS1 rs2737229 and TRIB1 rs2954029 Genetic Polymorphisms with Subclinical Atherosclerosis, LDL Cholesterol, and Glucose Levels},
journal = {Biology},
year = {2026},
volume = {15},
number = {7},
pages = {580},
doi = {10.3390/biology15070580}
}
EUVIMED